Dr. med. Ozgür Yaldizli
Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS.
Cagol A, Benkert P, Melie-Garcia L, Schaedelin S, Leber S, Tsagkas C, Barakovic M, Galbusera R, Lu P, Weigel M, Ruberte E, Radue E, Yaldizli O, Oechtering J, Lorscheider J, D'Souza M, Fischer-Barnicol B, Müller S, Achtnichts L, Vehoff J, Giulio D, Findling O, Chan A, Salmen A, Pot C, Bridel C, Zecca C, Derfuss T, Lieb J, Remonda L, Wagner F, Vargas M, Du Pasquier R, Lalive P, Pravatà E, Weber J, Cattin P, Absinta M, Gobbi C, Leppert D, Kappos L, Kuhle J, Granziera C. Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS. Neurology 2023; 102:e207768.
Dec 13, 2023Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS.
Dec 13, 2023Neurology 2023; 102:e207768
Cagol Alessandro, Benkert Pascal, Melie-Garcia Lester, Schaedelin Sabine A, Leber Selina, Tsagkas Charidimos, Barakovic Muhamed, Galbusera Riccardo, Lu Po-Jui, Weigel Matthias, Ruberte Esther, Radue Ernst-Wilhelm, Yaldizli Ozgür, Oechtering Johanna, Lorscheider Johannes, D'Souza Marcus, Fischer-Barnicol Bettina, Müller Stefanie, Achtnichts Lutz, Vehoff Jochen, Giulio Disanto, Findling Oliver, Chan Andrew T, Salmen Anke, Pot Caroline, Bridel Claire, Zecca Chiara, Derfuss Tobias, Lieb Johanna Maria, Remonda Luca, Wagner Franca, Vargas Maria Isabel, Du Pasquier Renaud A, Lalive Patrice H, Pravatà Emanuele, Weber Johannes, Cattin Philippe C, Absinta Martina, Gobbi Claudio, Leppert David, Kappos Ludwig, Kuhle Jens, Granziera Cristina
Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis.
Meier S, Willemse E, Schaedelin S, Oechtering J, Lorscheider J, Melie-Garcia L, Cagol A, Barakovic M, Galbusera R, Subramaniam S, Barro C, Abdelhak A, Thebault S, Achtnichts L, Lalive P, Müller S, Pot C, Salmen A, Giulio D, Zecca C, D'Souza M, Orleth A, Khalil M, Buchmann A, Du Pasquier R, Yaldizli O, Derfuss T, Berger K, Hermesdorf M, Wiendl H, Piehl F, Battaglini M, Fischer U, Kappos L, Gobbi C, Granziera C, Bridel C, Leppert D, Maceski A, Benkert P, Kuhle J. Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis. JAMA Neurol 2023; 80:287-297.
Mar 1, 2023Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis.
Mar 1, 2023JAMA Neurol 2023; 80:287-297
Meier Stephanie, Willemse Eline A J, Schaedelin Sabine A, Oechtering Johanna, Lorscheider Johannes, Melie-Garcia Lester, Cagol Alessandro, Barakovic Muhamed, Galbusera Riccardo, Subramaniam Suvitha, Barro Christian, Abdelhak Ahmed, Thebault Simon, Achtnichts Lutz, Lalive Patrice H, Müller Stefanie, Pot Caroline, Salmen Anke, Giulio Disanto, Zecca Chiara, D'Souza Marcus, Orleth Annette, Khalil Michael, Buchmann Arabella, Du Pasquier Renaud A, Yaldizli Ozgür, Derfuss Tobias, Berger Klaus, Hermesdorf Marco, Wiendl Heinz, Piehl Fredrik, Battaglini Marco, Fischer Urs, Kappos Ludwig, Gobbi Claudio, Granziera Cristina, Bridel Claire, Leppert David, Maceski Aleksandra Maleska, Benkert Pascal, Kuhle Jens
Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis.
Cagol A, Schaedelin S, Barakovic M, Benkert P, Todea R, Rahmanzadeh R, Galbusera R, Lu P, Weigel M, Melie-Garcia L, Ruberte E, Siebenborn N, Battaglini M, Radue E, Yaldizli O, Oechtering J, Sinnecker T, Lorscheider J, Fischer-Barnicol B, Müller S, Achtnichts L, Vehoff J, Giulio D, Findling O, Chan A, Salmen A, Pot C, Bridel C, Zecca C, Derfuss T, Lieb J, Remonda L, Wagner F, Vargas M, Du Pasquier R, Lalive P, Pravatà E, Weber J, Cattin P, Gobbi C, Leppert D, Kappos L, Kuhle J, Granziera C. Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis. JAMA Neurol 2022; 79:682-692.
Jul 1, 2022Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis.
Jul 1, 2022JAMA Neurol 2022; 79:682-692
Cagol Alessandro, Schaedelin Sabine A, Barakovic Muhamed, Benkert Pascal, Todea Ramona-Alexandra, Rahmanzadeh Reza, Galbusera Riccardo, Lu Po-Jui, Weigel Matthias, Melie-Garcia Lester, Ruberte Esther, Siebenborn Nina, Battaglini Marco, Radue Ernst-Wilhelm, Yaldizli Ozgür, Oechtering Johanna, Sinnecker Tim, Lorscheider Johannes, Fischer-Barnicol Bettina, Müller Stefanie, Achtnichts Lutz, Vehoff Jochen, Giulio Disanto, Findling Oliver, Chan Andrew T, Salmen Anke, Pot Caroline, Bridel Claire, Zecca Chiara, Derfuss Tobias, Lieb Johanna Maria, Remonda Luca, Wagner Franca, Vargas Maria I, Du Pasquier Renaud A, Lalive Patrice H, Pravatà Emanuele, Weber Johannes, Cattin Philippe C, Gobbi Claudio, Leppert David, Kappos Ludwig, Kuhle Jens, Granziera Cristina
Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study.
Benkert P, Meier S, Schaedelin S, Manouchehrinia A, Yaldizli O, Maceski A, Oechtering J, Achtnichts L, Conen D, Derfuss T, Lalive P, Mueller C, Müller S, Naegelin Y, Oksenberg J, Pot C, Salmen A, Willemse E, Kockum I, Blennow K, Zetterberg H, Gobbi C, Kappos L, Wiendl H, Berger K, Sormani M, Granziera C, Piehl F, Leppert D, Kuhle J. Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study. Lancet Neurol 2022; 21:246-257.
Mar 1, 2022Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study.
Mar 1, 2022Lancet Neurol 2022; 21:246-257
Benkert Pascal, Meier Stephanie, Schaedelin Sabine, Manouchehrinia Ali, Yaldizli Ozgür, Maceski Aleksandra, Oechtering Johanna, Achtnichts Lutz, Conen David, Derfuss Tobias, Lalive Patrice H, Mueller Christian, Müller Stefanie, Naegelin Yvonne, Oksenberg Jorge R, Pot Caroline, Salmen Anke, Willemse Eline, Kockum Ingrid, Blennow Kaj, Zetterberg Henrik, Gobbi Claudio, Kappos Ludwig, Wiendl Heinz, Berger Klaus, Sormani Maria Pia, Granziera Cristina, Piehl Fredrik, Leppert David, Kuhle Jens
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis
Oechtering J, Naegelin Y, Maceski A, Meier S, Berger K, Wiendl H, Lincke T, Lieb J, Yaldizli O, Sinnecker T, Derfuss T, Regeniter A, Zecca C, Gobbi C, Kappos L, Granziera C, Leppert D, Kuhle J, Conen D, Aeschbacher S, Subramaniam S, Schaedelin S, Benkert P, Müller S, Achtnichts L, Vehoff J, Giulio D, Findling O, Fischer-Barnicol B, Orleth A, Chan A, Pot C, Barakovic M, Rahmanzadeh R, Galbusera R, Heijnen I, Lalive P, Wuerfel J, Swiss Multiple Sclerosis Cohort Study. Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis. Ann Neurol 2021; 90:477-489.
Jun 22, 2021Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis
Jun 22, 2021Ann Neurol 2021; 90:477-489
Oechtering Johanna, Naegelin Yvonne, Maceski Aleksandra, Meier Stephanie, Berger Klaus, Wiendl Heinz, Lincke Therese, Lieb Johanna, Yaldizli Ozgür, Sinnecker Tim, Derfuss Tobias, Regeniter Axel, Zecca Chiara, Gobbi Claudio, Kappos Ludwig, Granziera Cristina, Leppert David, Kuhle Jens, Conen David, Aeschbacher Stefanie, Subramaniam Suvitha, Schaedelin Sabine, Benkert Pascal, Müller Stefanie, Achtnichts Lutz, Vehoff Jochen, Giulio Disanto, Findling Oliver, Fischer-Barnicol Bettina, Orleth Annette, Chan Andrew, Pot Caroline, Barakovic Muhamed, Rahmanzadeh Reza, Galbusera Riccardo, Heijnen Ingmar, Lalive Patrice H, Wuerfel Jens, Swiss Multiple Sclerosis Cohort Study
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options
Giulio D, Kamm C, Mattle H, Lotter C, Du Pasquier R, Schluep M, Pot C, Lalive P, Yaldizli O, Gobbi C, Kappos L, Kuhle J, Louvion J, Derfuss T, Stippich C, Benkert P, Lorscheider J, Müller S, Vehoff J, Zecca C, Ramseier S, Achtnichts L, Findling O, Nedeltchev K, Radue E, Sprenger T, SMSC Scientific Board. The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options. PloS one 2016; 11:e0152347.
Mar 31, 2016The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options
Mar 31, 2016PloS one 2016; 11:e0152347
Giulio Disanto, Kamm Christian P, Mattle Heinrich P, Lotter Christoph, Du Pasquier Renaud, Schluep Myriam, Pot Caroline, Lalive Patrice H, Yaldizli Ozgür, Gobbi Claudio, Kappos Ludwig, Kuhle Jens, Louvion Jean-François, Derfuss Tobias, Stippich Christoph, Benkert Pascal, Lorscheider Johannes, Müller Stefanie, Vehoff Jochen, Zecca Chiara, Ramseier Simon, Achtnichts Lutz, Findling Oliver, Nedeltchev Krassen, Radue Ernst-Wilhelm, Sprenger Till, SMSC Scientific Board
Brain metabolites and retinal nerve fibre layer thickness and their relation to disability in multiple sclerosis: a longitudinal high-field proton magnetic resonance spectroscopy and optical coherence tomography study
Pardini M, Putzki N, Tettenborn B, Valmaggia C, Würfel J, Gass A, Kuhle J, Vehoff J, Müller S, Botzkowski D, Yaldizli O (2015). Brain metabolites and retinal nerve fibre layer thickness and their relation to disability in multiple sclerosis: a longitudinal high-field proton magnetic resonance spectroscopy and optical coherence tomography study.
Oct 7, 2015Brain metabolites and retinal nerve fibre layer thickness and their relation to disability in multiple sclerosis: a longitudinal high-field proton magnetic resonance spectroscopy and optical coherence tomography study
Oct 7, 2015ECTRIMS 2015
Pardini M., Putzki Norman, Tettenborn Barbara, Valmaggia Christophe, Würfel Jens, Gass Andrea, Kuhle Jens, Vehoff Jochen, Müller Stefanie, Botzkowski D., Yaldizli Ozgür
Fatigue and progression of corpus callosum atrophy in multiple sclerosis
Yaldizli O, Glassl S, Sturm D, Papadopoulou A, Gass A, Tettenborn B, Putzki N. Fatigue and progression of corpus callosum atrophy in multiple sclerosis. J Neurol 2011; 258:2199-205.
May 19, 2011Fatigue and progression of corpus callosum atrophy in multiple sclerosis
May 19, 2011J Neurol 2011; 258:2199-205
Yaldizli Ozgür, Glassl Stephanie, Sturm Dietrich, Papadopoulou Athina, Gass Achim, Tettenborn Barbara, Putzki Norman
Corpus callosum index and long-term disability in multiple sclerosis patients
Yaldizli O, Atefy R, Gass A, Sturm D, Glassl S, Tettenborn B, Putzki N. Corpus callosum index and long-term disability in multiple sclerosis patients. J Neurol 2010; 257:1256-64.
Mar 3, 2010Corpus callosum index and long-term disability in multiple sclerosis patients
Mar 3, 2010J Neurol 2010; 257:1256-64
Yaldizli Ozgür, Atefy Ramin, Gass Achim, Sturm Dietrich, Glassl Stephanie, Tettenborn Barbara, Putzki Norman
Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland
Putzki N, Yaldizli O, Bühler R, Schwegler G, Curtius D, Tettenborn B. Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland. Eur Neurol 2010; 63:101-106.
Jan 1, 2010Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland
Jan 1, 2010Eur Neurol 2010; 63:101-106
Putzki Norman, Yaldizli Ozgür, Bühler Robert, Schwegler Guido, Curtius Daniela, Tettenborn Barbara
Multiple sclerosis associated fatigue during natalizumab treatment
Putzki N, Yaldizli O, Tettenborn B, Diener H. Multiple sclerosis associated fatigue during natalizumab treatment. Journal of the neurological sciences 2009; 285:109-13.
Oct 15, 2009Multiple sclerosis associated fatigue during natalizumab treatment
Oct 15, 2009Journal of the neurological sciences 2009; 285:109-13
Putzki Norman, Yaldizli Ozgür, Tettenborn Barbara, Diener Hans Christoph
Pain in the sole of the foot. Have you suspected its cause in the knee?
Yaldizli O, Coco O, Hundsberger T, Tettenborn B. Pain in the sole of the foot. Have you suspected its cause in the knee?. MMW Fortschritte der Medizin 2009; 151:5.
May 7, 2009Pain in the sole of the foot. Have you suspected its cause in the knee?
May 7, 2009MMW Fortschritte der Medizin 2009; 151:5
Yaldizli Ozgür, Coco Oracio, Hundsberger Thomas, Tettenborn Barbara
Fatigue bei therapierten und untherapierten Patienten mit schubförmiger und sekundär progredienter Multipler Sklerose
Putzki N, Yaldizli O, Tettenborn B. Fatigue bei therapierten und untherapierten Patienten mit schubförmiger und sekundär progredienter Multipler Sklerose. Aktuelle Neurologie 2008; 9
Sep 24, 2008Fatigue bei therapierten und untherapierten Patienten mit schubförmiger und sekundär progredienter Multipler Sklerose
Sep 24, 2008Aktuelle Neurologie 2008; 9
Putzki Norman, Yaldizli Ozgür, Tettenborn Barbara